Furthermore, hypoxia inducible factor-1α (HIF-1α) and its downstream target genes, such as VEGF, could regulate the cell response to hypoxia, and might confer resistance to radiotherapy of prostate cancer. This evidence concerns the gene VEGFA and prostate cancer.